GlycoMimetics Inc (GLYC)

0.242 +0.03 (+11.78%) USD  |  NASDAQ  |  Dec 24, 16:00
More

GlycoMimetics Free Cash Flow to Firm (Quarterly)

Free Cash Flow to Firm (Quarterly) Chart

View Free Cash Flow to Firm (Quarterly) for GLYC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow to Firm (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow to the Firm Definition

View Free Cash Flow to the Firm Definition
Start Trial

Free cash flow to firm measures the total cash flow available after all expenses and investments. This metric can give a good idea of the health of a company's operations.

Read full definition.

Free Cash Flow to Firm (Quarterly) Range, Past 5 Years

View Free Cash Flow to Firm (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow to Firm (Quarterly) Benchmarks

View Free Cash Flow to Firm (Quarterly) Benchmarks
Start Trial
Biomarin Pharmaceutical Inc Upgrade
Arbutus Biopharma Corp --
Revance Therapeutics Inc Upgrade
FibroGen Inc Upgrade
Cidara Therapeutics Inc --

Free Cash Flow to Firm (Quarterly) Related Metrics

Cash from Operations (Quarterly) Upgrade
Free Cash Flow Upgrade
Free Cash Flow Per Share (Quarterly) Upgrade
Free Cash Flow Yield Upgrade